Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine.
- Sector(s): Healthcare
- Industry: Medical Instruments & Supplies
- Full Time Employees: 138
- http://singulargenomics.com
Opened at $29.00 after pricing 10.2 mln share IPO at $22.00 per share, at the high end of the $20-22 expected range
No comments:
Post a Comment